NCT07919158Active, not recruiting
Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): A Study at the San Raffaele Hospital Center for Metabolic Health
Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): An Observational, Retrospective Cohort Study at the San Raffaele Hospital Center for Metabolic Health
Source: ClinicalTrials.gov · Last updated 5 Nov 2026
Brief summary (registry, in English)
A single-center, retrospective, observational study without experimental intervention, conducted at the Center of Excellence for Metabolic Health at IRCCS San Raffaele Hospital. The primary objective of the study is to estimate the prevalence of dyslipidemia and evaluate its association with metabolic health status in overweight or obese subjects. Secondary objectives include characterizing cardiovascular risk; evaluating lipid, glycemic, and inflammatory profiles; analyzing longitudinal changes in these parameters during follow-up (where available); assessing the achievement of therapeutic targets recommended by ESC/EAS guidelines; and identifying predictors of metabolic response. Approximately 900 patients are expected to be included, all enrolled at the Center of Excellence for Metabolic Health at IRCCS San Raffaele Hospital. Therefore, the total number of patients corresponds to that of the participating center.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 900 (estimated)
- First submitted
- 25 Sept 2026
- Start date
- 1 Oct 2024
- Primary completion date
- 30 Jul 2026
- Lead sponsor
- Rovere Querini Patrizia
- Diseases
- Obesity
- NCT number
- NCT07919158
What you commit to
- Study type: Observational
- Planned participants: 900
- From 1 Oct 2024 to the primary completion date, 30 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None. Given the retrospective observational nature of the study and its alignment with routine clinical practice, no exclusion criteria are applied. All patients meeting the predefined inclusion criteria are eligible for inclusion, with no additional selection
Who the study is looking for
- Age ≥ 18 years; overweight/obesity.
- BMI ≥ 25 kg/m2
- Availability of complete baseline Iipid profile (TC, LDL.-C, TG, HDL-C)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS San Raffaele Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.